A-SEEDS is a biotech company that researches and develops regenerative medicines, especially for cancer patients.
A-SEEDS has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in July 2025.
A-SEEDS's investors include Mizuho Capital, SMBC Venture Capital, Delight Ventures, Nippon Venture Capital, Osaka University Venture Capital.
A-SEEDS is headquartered in Matsumoto, Japan.
A-SEEDS is a biotech company that researches and develops regenerative medicines, especially for cancer patients.
A-SEEDS is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"A-SEEDS — Funding & Investors." VCBacked, July 7, 2025, https://www.vcbacked.co/company/a-seeds. Accessed July 20, 2026.
VCBacked. (2025). A-SEEDS — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/a-seeds
{{cite web |title=A-SEEDS — Funding & Investors |url=https://www.vcbacked.co/company/a-seeds |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated